These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
102 related articles for article (PubMed ID: 27753680)
41. Reactivation capacity by latency-reversing agents ex vivo correlates with the size of the HIV-1 reservoir. Darcis G; Bouchat S; Kula A; Van Driessche B; Delacourt N; Vanhulle C; Avettand-Fenoel V; De Wit S; Rohr O; Rouzioux C; Van Lint C AIDS; 2017 Jan; 31(2):181-189. PubMed ID: 27755105 [TBL] [Abstract][Full Text] [Related]
42. Antibodies to S2 domain of SARS-CoV-2 spike protein in Moderna mRNA vaccinated subjects sustain antibody-dependent NK cell-mediated cell cytotoxicity against Omicron BA.1. Balinsky CA; Jiang L; Jani V; Cheng Y; Zhang Z; Belinskaya T; Qiu Q; Long TK; Schilling MA; Jenkins SA; Corson KS; Martin NJ; Letizia AG; Hontz RD; Sun P Front Immunol; 2023; 14():1266829. PubMed ID: 38077368 [TBL] [Abstract][Full Text] [Related]
43. Antiviral antibody responses to systemic administration of an oncolytic RNA virus: the impact of standard concomitant anticancer chemotherapies. Roulstone V; Mansfield D; Harris RJ; Twigger K; White C; de Bono J; Spicer J; Karagiannis SN; Vile R; Pandha H; Melcher A; Harrington K J Immunother Cancer; 2021 Jul; 9(7):. PubMed ID: 34301814 [TBL] [Abstract][Full Text] [Related]
44. Effect of polymorphisms in porcine guanylate-binding proteins on host resistance to PRRSV infection in experimentally challenged pigs. Khatun A; Nazki S; Jeong CG; Gu S; Mattoo SUS; Lee SI; Yang MS; Lim B; Kim KS; Kim B; Lee KT; Park CK; Lee SM; Kim WI Vet Res; 2020 Feb; 51(1):14. PubMed ID: 32075688 [TBL] [Abstract][Full Text] [Related]
45. Update on Fc-Mediated Antibody Functions Against HIV-1 Beyond Neutralization. Su B; Dispinseri S; Iannone V; Zhang T; Wu H; Carapito R; Bahram S; Scarlatti G; Moog C Front Immunol; 2019; 10():2968. PubMed ID: 31921207 [TBL] [Abstract][Full Text] [Related]
46. A Recombinant Rabies Virus Expressing the Marburg Virus Glycoprotein Is Dependent upon Antibody-Mediated Cellular Cytotoxicity for Protection against Marburg Virus Disease in a Murine Model. Keshwara R; Hagen KR; Abreu-Mota T; Papaneri AB; Liu D; Wirblich C; Johnson RF; Schnell MJ J Virol; 2019 Mar; 93(6):. PubMed ID: 30567978 [TBL] [Abstract][Full Text] [Related]
47. Humoral immunity to HIV, SIV, and SHIV. Haigwood NL; Zolla-Pazner S AIDS; 1998; 12 Suppl A():S121-32. PubMed ID: 9632993 [No Abstract] [Full Text] [Related]
49. Non-neutralizing antibody functions for protection and control HIV in humans and SIV and SHIV in non-human primates. Zolla-Pazner S AIDS; 2016 Oct; 30(16):2551-2553. PubMed ID: 27753680 [No Abstract] [Full Text] [Related]
50. Protection of rhesus monkeys against infection with minimally pathogenic simian-human immunodeficiency virus: correlations with neutralizing antibodies and cytotoxic T cells. Quinnan GV; Yu XF; Lewis MG; Zhang PF; Sutter G; Silvera P; Dong M; Choudhary A; Sarkis PT; Bouma P; Zhang Z; Montefiori DC; Vancott TC; Broder CC J Virol; 2005 Mar; 79(6):3358-69. PubMed ID: 15731230 [TBL] [Abstract][Full Text] [Related]
51. Vaccination of rhesus macaques with recombinant Mycobacterium bovis bacillus Calmette-Guérin Env V3 elicits neutralizing antibody-mediated protection against simian-human immunodeficiency virus with a homologous but not a heterologous V3 motif. Someya K; Cecilia D; Ami Y; Nakasone T; Matsuo K; Burda S; Yamamoto H; Yoshino N; Kaizu M; Ando S; Okuda K; Zolla-Pazner S; Yamazaki S; Yamamoto N; Honda M J Virol; 2005 Feb; 79(3):1452-62. PubMed ID: 15650171 [TBL] [Abstract][Full Text] [Related]
52. Fc receptor but not complement binding is important in antibody protection against HIV. Hessell AJ; Hangartner L; Hunter M; Havenith CE; Beurskens FJ; Bakker JM; Lanigan CM; Landucci G; Forthal DN; Parren PW; Marx PA; Burton DR Nature; 2007 Sep; 449(7158):101-4. PubMed ID: 17805298 [TBL] [Abstract][Full Text] [Related]
53. Protection of macaques against vaginal transmission of a pathogenic HIV-1/SIV chimeric virus by passive infusion of neutralizing antibodies. Mascola JR; Stiegler G; VanCott TC; Katinger H; Carpenter CB; Hanson CE; Beary H; Hayes D; Frankel SS; Birx DL; Lewis MG Nat Med; 2000 Feb; 6(2):207-10. PubMed ID: 10655111 [TBL] [Abstract][Full Text] [Related]
54. Development of Broadly Neutralizing Antibodies and Their Mapping by Monomeric gp120 in Human Immunodeficiency Virus Type 1-Infected Humans and Simian-Human Immunodeficiency Virus SHIVSF162P3N-Infected Macaques. Jia M; Lu H; Markowitz M; Cheng-Mayer C; Wu X J Virol; 2016 Apr; 90(8):4017-4031. PubMed ID: 26842476 [TBL] [Abstract][Full Text] [Related]